Market Watch

NYSE, Deutsche Boerse address antitrust concerns

 By Barbara Kollmeyer    ||  Dec. 13, 2011, 2:43 a.m. EST

MADRID (MarketWatch) -- NYSE Euronext NYX -0.04% and Deutsche Boerse AG DE:DB1 +0.30% on Tuesday said they've submitted revised remedies to the European Commission's competition regulator amid the body's concerns the $9 billion merger would reduce competition in the derivatives sector. The two sides said they'll increase the assets to be divested; they'll ensure that whoever buys that business has access to the combined firm's clearing house; and they'll license the Eurex trading system to third parties that want to launch interest-rate derivatives. The EU will now have until Feb. 9 to complete its review and closing of the deal is anticipated early 2012